Global pharma giant GlaxoSmithKline Pharmaceuticals Ltd received an income tax refund of ₹222.23 crore for the assessment year 2022-23, following an order issued by the Income Tax Department on Tuesday.
Global healthcare major informed in regulatory filings of an Income Tax Order for Assessment Year 2022-23 issuing income tax refund of Rs 222.23 cr including interest.
GlaxoSmithKline Pharmaceuticals declared a 37.8% year-on-year (YoY) increase in net profit to Rs.182.3 crore in the first quarter ended June 30, 2024. GlaxoSmithKline’s net profit in the same quarter was Rs.132.3 crore while revenue rose by 7% to Rs.814.7 crore from Rs.761.7 crore in the same period last year
Delhi Police Arrest Man For Stabbing Wife Amid Marital Dispute In Brahmpuri; Victim Undergoing Treatment At JPC Hospital
Election Commission Delegation Led By CEC Gyanesh Kumar Arrives In Patna To Review Bihar Assembly Poll Preparations
Japan: Sanae Takaichi Wins Ruling Party Leader Race, Set To Become First Female PM On October 15
India's Coffee Exports Soar 15% At $1.05 Billion, Continues To Be Seventh Largest Producer & Fifth Major Exporter
